TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global and United States Dog Prescription Drugs Market Report & Forecast 2022-2028

Global and United States Dog Prescription Drugs Market Report & Forecast 2022-2028

  • Category:Life Sciences
  • Published on : 21 September 2022
  • Pages :104
  • Formats:
  • Report Code:SMR-7375368
OfferClick for best price

Best Price: $3480

Dog Prescription Drugs Market Size, Share 2022


Market Analysis and Insights: Global Dog Prescription Drugs Market

The global Dog Prescription Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Dog Prescription Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Dog Prescription Drugs market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Dog Prescription Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Dog Prescription Drugs market.

Global Dog Prescription Drugs Scope and Market Size

Dog Prescription Drugs market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Dog Prescription Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.

For United States market, this report focuses on the Dog Prescription Drugs market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.

Segment by Type

Oral Type

Smear Type

Injection Type

Spray Type

Segment by Application

Hospital

Clinic

Others

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

By Company

Elanco Animal Health

Ceva Sante Animale

MSD Animal Health

Zoetis

Virbac

Dechra

Vetoquinol

Animalcare Group

Ourofino Saude Animal

Boehringer Ingelheim

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Dog Prescription Drugs product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Dog Prescription Drugs, with price, sales, revenue, and global market share of Dog Prescription Drugs from 2019 to 2022.

Chapter 3, the Dog Prescription Drugs competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Dog Prescription Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Dog Prescription Drugs market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Dog Prescription Drugs.

Chapter 13, 14, and 15, to describe Dog Prescription Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Dog Prescription Drugs Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global and United States Dog Prescription Drugs Market Report & Forecast 2022-2028
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 104 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Study Coverage
1.1 Dog Prescription Drugs Product Introduction
1.2 Global Dog Prescription Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Dog Prescription Drugs Sales in US$ Million for the Year 2017-2028
1.2.2 Global Dog Prescription Drugs Sales in Volume for the Year 2017-2028
1.3 United States Dog Prescription Drugs Outlook 2017 VS 2022 VS 2028
1.3.1 United States Dog Prescription Drugs Sales in US$ Million for the Year 2017-2028
1.3.2 United States Dog Prescription Drugs Sales in Volume for the Year 2017-2028
1.4 Dog Prescription Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Dog Prescription Drugs in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Dog Prescription Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Dog Prescription Drugs Market Dynamics
1.5.1 Dog Prescription Drugs Industry Trends
1.5.2 Dog Prescription Drugs Market Drivers
1.5.3 Dog Prescription Drugs Market Challenges
1.5.4 Dog Prescription Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Dog Prescription Drugs Market Segment by Type
2.1.1 Oral Type
2.1.2 Smear Type
2.1.3 Injection Type
2.1.4 Spray Type
2.2 Global Dog Prescription Drugs Market Size by Type
2.2.1 Global Dog Prescription Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Dog Prescription Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Dog Prescription Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Dog Prescription Drugs Market Size by Type
2.3.1 United States Dog Prescription Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Dog Prescription Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Dog Prescription Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Dog Prescription Drugs Market Segment by Application
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Others
3.2 Global Dog Prescription Drugs Market Size by Application
3.2.1 Global Dog Prescription Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Dog Prescription Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Dog Prescription Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Dog Prescription Drugs Market Size by Application
3.3.1 United States Dog Prescription Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Dog Prescription Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Dog Prescription Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Dog Prescription Drugs Competitor Landscape by Company
4.1 Global Dog Prescription Drugs Market Size by Company
4.1.1 Top Global Dog Prescription Drugs Manufacturers Ranked by Revenue (2021)
4.1.2 Global Dog Prescription Drugs Revenue by Manufacturer (2017-2022)
4.1.3 Global Dog Prescription Drugs Sales by Manufacturer (2017-2022)
4.1.4 Global Dog Prescription Drugs Price by Manufacturer (2017-2022)
4.2 Global Dog Prescription Drugs Concentration Ratio (CR)
4.2.1 Dog Prescription Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Dog Prescription Drugs in 2021
4.2.3 Global Dog Prescription Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Dog Prescription Drugs Manufacturing Base Distribution, Product Type
4.3.1 Global Dog Prescription Drugs Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Dog Prescription Drugs Product Type
4.3.3 Date of International Manufacturers Enter into Dog Prescription Drugs Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Dog Prescription Drugs Market Size by Company
4.5.1 Top Dog Prescription Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Dog Prescription Drugs Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Dog Prescription Drugs Sales by Players (2020, 2021 & 2022)
5 Global Dog Prescription Drugs Market Size by Region
5.1 Global Dog Prescription Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Dog Prescription Drugs Market Size in Volume by Region (2017-2028)
5.2.1 Global Dog Prescription Drugs Sales in Volume by Region: 2017-2022
5.2.2 Global Dog Prescription Drugs Sales in Volume Forecast by Region (2023-2028)
5.3 Global Dog Prescription Drugs Market Size in Value by Region (2017-2028)
5.3.1 Global Dog Prescription Drugs Sales in Value by Region: 2017-2022
5.3.2 Global Dog Prescription Drugs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Dog Prescription Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Dog Prescription Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Dog Prescription Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Dog Prescription Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Dog Prescription Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Dog Prescription Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Dog Prescription Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Dog Prescription Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Dog Prescription Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Dog Prescription Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Elanco Animal Health
7.1.1 Elanco Animal Health Corporation Information
7.1.2 Elanco Animal Health Description and Business Overview
7.1.3 Elanco Animal Health Dog Prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Elanco Animal Health Dog Prescription Drugs Products Offered
7.1.5 Elanco Animal Health Recent Development
7.2 Ceva Sante Animale
7.2.1 Ceva Sante Animale Corporation Information
7.2.2 Ceva Sante Animale Description and Business Overview
7.2.3 Ceva Sante Animale Dog Prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Ceva Sante Animale Dog Prescription Drugs Products Offered
7.2.5 Ceva Sante Animale Recent Development
7.3 MSD Animal Health
7.3.1 MSD Animal Health Corporation Information
7.3.2 MSD Animal Health Description and Business Overview
7.3.3 MSD Animal Health Dog Prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
7.3.4 MSD Animal Health Dog Prescription Drugs Products Offered
7.3.5 MSD Animal Health Recent Development
7.4 Zoetis
7.4.1 Zoetis Corporation Information
7.4.2 Zoetis Description and Business Overview
7.4.3 Zoetis Dog Prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Zoetis Dog Prescription Drugs Products Offered
7.4.5 Zoetis Recent Development
7.5 Virbac
7.5.1 Virbac Corporation Information
7.5.2 Virbac Description and Business Overview
7.5.3 Virbac Dog Prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Virbac Dog Prescription Drugs Products Offered
7.5.5 Virbac Recent Development
7.6 Dechra
7.6.1 Dechra Corporation Information
7.6.2 Dechra Description and Business Overview
7.6.3 Dechra Dog Prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Dechra Dog Prescription Drugs Products Offered
7.6.5 Dechra Recent Development
7.7 Vetoquinol
7.7.1 Vetoquinol Corporation Information
7.7.2 Vetoquinol Description and Business Overview
7.7.3 Vetoquinol Dog Prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Vetoquinol Dog Prescription Drugs Products Offered
7.7.5 Vetoquinol Recent Development
7.8 Animalcare Group
7.8.1 Animalcare Group Corporation Information
7.8.2 Animalcare Group Description and Business Overview
7.8.3 Animalcare Group Dog Prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Animalcare Group Dog Prescription Drugs Products Offered
7.8.5 Animalcare Group Recent Development
7.9 Ourofino Saude Animal
7.9.1 Ourofino Saude Animal Corporation Information
7.9.2 Ourofino Saude Animal Description and Business Overview
7.9.3 Ourofino Saude Animal Dog Prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Ourofino Saude Animal Dog Prescription Drugs Products Offered
7.9.5 Ourofino Saude Animal Recent Development
7.10 Boehringer Ingelheim
7.10.1 Boehringer Ingelheim Corporation Information
7.10.2 Boehringer Ingelheim Description and Business Overview
7.10.3 Boehringer Ingelheim Dog Prescription Drugs Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Boehringer Ingelheim Dog Prescription Drugs Products Offered
7.10.5 Boehringer Ingelheim Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Dog Prescription Drugs Industry Chain Analysis
8.2 Dog Prescription Drugs Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Dog Prescription Drugs Distributors
8.3 Dog Prescription Drugs Production Mode & Process
8.4 Dog Prescription Drugs Sales and Marketing
8.4.1 Dog Prescription Drugs Sales Channels
8.4.2 Dog Prescription Drugs Distributors
8.5 Dog Prescription Drugs Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Dog Prescription Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Dog Prescription Drugs Market Trends
Table 3. Dog Prescription Drugs Market Drivers
Table 4. Dog Prescription Drugs Market Challenges
Table 5. Dog Prescription Drugs Market Restraints
Table 6. Global Dog Prescription Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Dog Prescription Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Dog Prescription Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Dog Prescription Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Dog Prescription Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Dog Prescription Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Dog Prescription Drugs Revenue Share by Manufacturer, 2017-2022
Table 13. Global Dog Prescription Drugs Sales by Manufacturer, (K Units), 2017-2022
Table 14. Global Dog Prescription Drugs Sales Share by Manufacturer, 2017-2022
Table 15. Global Dog Prescription Drugs Price by Manufacturer (2017-2022) & (USD/Unit)
Table 16. Global Dog Prescription Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Dog Prescription Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dog Prescription Drugs as of 2021)
Table 18. Top Players of Dog Prescription Drugs in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Dog Prescription Drugs Product Type
Table 20. Date of International Manufacturers Enter into Dog Prescription Drugs Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Dog Prescription Drugs Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Dog Prescription Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Dog Prescription Drugs Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Dog Prescription Drugs Sales by Players, (K Units), 2020, 2021 & 2022
Table 26. United States Dog Prescription Drugs Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Dog Prescription Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Dog Prescription Drugs Sales in Volume by Region (2017-2022) & (K Units)
Table 29. Global Dog Prescription Drugs Sales in Volume Forecast by Region (2023-2028) & (K Units)
Table 30. Global Dog Prescription Drugs Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Dog Prescription Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Dog Prescription Drugs Sales in Volume by Country (2017-2028) & (K Units)
Table 33. North America Dog Prescription Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Dog Prescription Drugs Sales in Volume by Region (2017-2028) & (K Units)
Table 35. Asia Pacific Dog Prescription Drugs Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Dog Prescription Drugs Sales in Volume by Country (2017-2028) & (K Units)
Table 37. Europe Dog Prescription Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Dog Prescription Drugs Sales in Volume by Country (2017-2028) & (K Units)
Table 39. Latin Americaa Dog Prescription Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Dog Prescription Drugs Sales in Volume by Country (2017-2028) & (K Units)
Table 41. Middle East and Africa Dog Prescription Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Elanco Animal Health Corporation Information
Table 43. Elanco Animal Health Description and Business Overview
Table 44. Elanco Animal Health Dog Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 45. Elanco Animal Health Dog Prescription Drugs Product
Table 46. Elanco Animal Health Recent Development
Table 47. Ceva Sante Animale Corporation Information
Table 48. Ceva Sante Animale Description and Business Overview
Table 49. Ceva Sante Animale Dog Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 50. Ceva Sante Animale Product
Table 51. Ceva Sante Animale Recent Development
Table 52. MSD Animal Health Corporation Information
Table 53. MSD Animal Health Description and Business Overview
Table 54. MSD Animal Health Dog Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 55. MSD Animal Health Product
Table 56. MSD Animal Health Recent Development
Table 57. Zoetis Corporation Information
Table 58. Zoetis Description and Business Overview
Table 59. Zoetis Dog Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 60. Zoetis Product
Table 61. Zoetis Recent Development
Table 62. Virbac Corporation Information
Table 63. Virbac Description and Business Overview
Table 64. Virbac Dog Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. Virbac Product
Table 66. Virbac Recent Development
Table 67. Dechra Corporation Information
Table 68. Dechra Description and Business Overview
Table 69. Dechra Dog Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 70. Dechra Product
Table 71. Dechra Recent Development
Table 72. Vetoquinol Corporation Information
Table 73. Vetoquinol Description and Business Overview
Table 74. Vetoquinol Dog Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 75. Vetoquinol Product
Table 76. Vetoquinol Recent Development
Table 77. Animalcare Group Corporation Information
Table 78. Animalcare Group Description and Business Overview
Table 79. Animalcare Group Dog Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 80. Animalcare Group Product
Table 81. Animalcare Group Recent Development
Table 82. Ourofino Saude Animal Corporation Information
Table 83. Ourofino Saude Animal Description and Business Overview
Table 84. Ourofino Saude Animal Dog Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 85. Ourofino Saude Animal Product
Table 86. Ourofino Saude Animal Recent Development
Table 87. Boehringer Ingelheim Corporation Information
Table 88. Boehringer Ingelheim Description and Business Overview
Table 89. Boehringer Ingelheim Dog Prescription Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 90. Boehringer Ingelheim Product
Table 91. Boehringer Ingelheim Recent Development
Table 92. Key Raw Materials Lists
Table 93. Raw Materials Key Suppliers Lists
Table 94. Dog Prescription Drugs Customers List
Table 95. Dog Prescription Drugs Distributors List
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Dog Prescription Drugs Product Picture
Figure 2. Global Dog Prescription Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Dog Prescription Drugs Market Size 2017-2028 (US$ Million)
Figure 4. Global Dog Prescription Drugs Sales 2017-2028 (K Units)
Figure 5. United States Dog Prescription Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Dog Prescription Drugs Market Size 2017-2028 (US$ Million)
Figure 7. United States Dog Prescription Drugs Sales 2017-2028 (K Units)
Figure 8. United States Dog Prescription Drugs Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Dog Prescription Drugs Market Share in Global, in Volume (K Units) 2017-2028
Figure 10. Dog Prescription Drugs Report Years Considered
Figure 11. Product Picture of Oral Type
Figure 12. Product Picture of Smear Type
Figure 13. Product Picture of Injection Type
Figure 14. Product Picture of Spray Type
Figure 15. Global Dog Prescription Drugs Market Share by Type in 2022 & 2028
Figure 16. Global Dog Prescription Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 17. Global Dog Prescription Drugs Sales Market Share in Value by Type (2017-2028)
Figure 18. Global Dog Prescription Drugs Sales by Type (2017-2028) & (K Units)
Figure 19. Global Dog Prescription Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 20. Global Dog Prescription Drugs Price by Type (2017-2028) & (USD/Unit)
Figure 21. United States Dog Prescription Drugs Market Share by Type in 2022 & 2028
Figure 22. United States Dog Prescription Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 23. United States Dog Prescription Drugs Sales Market Share in Value by Type (2017-2028)
Figure 24. United States Dog Prescription Drugs Sales by Type (2017-2028) & (K Units)
Figure 25. United States Dog Prescription Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 26. United States Dog Prescription Drugs Price by Type (2017-2028) & (USD/Unit)
Figure 27. Product Picture of Hospital
Figure 28. Product Picture of Clinic
Figure 29. Product Picture of Others
Figure 30. Global Dog Prescription Drugs Market Share by Application in 2022 & 2028
Figure 31. Global Dog Prescription Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 32. Global Dog Prescription Drugs Sales Market Share in Value by Application (2017-2028)
Figure 33. Global Dog Prescription Drugs Sales by Application (2017-2028) & (K Units)
Figure 34. Global Dog Prescription Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 35. Global Dog Prescription Drugs Price by Application (2017-2028) & (USD/Unit)
Figure 36. United States Dog Prescription Drugs Market Share by Application in 2022 & 2028
Figure 37. United States Dog Prescription Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 38. United States Dog Prescription Drugs Sales Market Share in Value by Application (2017-2028)
Figure 39. United States Dog Prescription Drugs Sales by Application (2017-2028) & (K Units)
Figure 40. United States Dog Prescription Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 41. United States Dog Prescription Drugs Price by Application (2017-2028) & (USD/Unit)
Figure 42. North America Dog Prescription Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 43. North America Dog Prescription Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 44. U.S. Dog Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 45. Canada Dog Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 46. Europe Dog Prescription Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 47. Europe Dog Prescription Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 48. Germany Dog Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. France Dog Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. U.K. Dog Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Italy Dog Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Russia Dog Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 53. Asia-Pacific Dog Prescription Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 54. Asia-Pacific Dog Prescription Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 55. China Dog Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. Japan Dog Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. South Korea Dog Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. India Dog Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Australia Dog Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Taiwan Dog Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Indonesia Dog Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Thailand Dog Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Malaysia Dog Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Philippines Dog Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 65. Latin America Dog Prescription Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 66. Latin America Dog Prescription Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 67. Mexico Dog Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Brazil Dog Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Argentina Dog Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 70. Middle East & Africa Dog Prescription Drugs Sales in Volume Growth Rate 2017-2028 (K Units)
Figure 71. Middle East & Africa Dog Prescription Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 72. Turkey Dog Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. Saudi Arabia Dog Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. U.A.E Dog Prescription Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 75. Dog Prescription Drugs Value Chain
Figure 76. Dog Prescription Drugs Production Process
Figure 77. Channels of Distribution
Figure 78. Distributors Profiles
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount